|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales and other operating revenues: | |||||
| Trade | |||||
| Related parties | |||||
| Total sales and other operating revenues: | |||||
| Operating costs and expenses: | |||||
| Cost of sales | |||||
| Impairments | |||||
| Goodwill impairments | |||||
| Other impairments | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Operating costs and expenses | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Interest income | |||||
| Gain (loss) on sale of business | |||||
| Other income (expense), net | |||||
| Income (loss) from continuing operations before equity investments and income taxes | |||||
| Loss from equity investments | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Provision for income taxes | |||||
| Income (loss) from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net (loss) income | |||||
| Dividends on redeemable non-controlling interests | |||||
| Net income (loss) attributable to the Company shareholders | |||||
| Earnings (loss) per share: | |||||
| Net income (loss) attributable to the Company shareholders —Basic: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic (in dollars in per share) | |||||
| Net income (loss) attributable to the Company shareholders - Diluted: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Diluted (in dollars per share) |
Loading...